Intact glycation end products containing carboxymethyl-lysine and glyoxal lysine dimer obtained from synthetic collagen model peptide

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 22, 2004, Pages 5677-5680

  Yamada, Hiroaki ^a   Sasaki, Tomoko ^a   Niwa, Sachiko ^a   Oishi, Tohru ^a   Murata, Michio ^a   Kawakami, Toru ^a   Aimoto, Saburo ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products; Collagen

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CARBOXYMETHYLLYSINE; DIMER; GLUCOSE; GLYOXAL; GLYOXAL LYSINE DIMER; LYSINE DERIVATIVE; RIBOSE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL MODIFICATION; CHEMICAL REACTION KINETICS; CONJUGATION; GLYCATION; PROTEIN STABILITY; PROTEIN STRUCTURE; REACTION ANALYSIS;

AMINO ACID SEQUENCE; COLLAGEN TYPE I; DIMERIZATION; GLYCOSYLATION END PRODUCTS, ADVANCED; GLYOXAL; HUMANS; LYSINE; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY;

EID: 5144232197     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.08.044     Document Type: Article

References (27)

1. A. Uchiyama, T. Ohishi, M. Takahashi, K. Kushida, T. Inoue, and M. Fujie J. Biochem. 110 1991 714 718
2. N. Vierzijl, J. DeGroot, E. Oldehinkel, R.A. Bank, S.R. Thorpe, and J.W. Baynes Biochem. J. 350 2000 381 387
3. M. Brownlee, H. Vlassara, A. Kooney, P. Ulrich, and A. Cerami Science 232 1986 1629 1632
4. S. Varan, P. Foiles, and H. Founds Arch. Biochem. Biophys. 419 2003 89 96
5. Z. Makita, S. Radoff, E.J. Rayfield, Z. Yang, and E. Skolnik New. Engl. J. Med. 325 1991 836 842
6. P. Mene, and F. Festucia G. Berlyne A. D’Angelo S. Favaro G. Gambaro Advanced Gycation End-Products in Nephrology 2000 Karger Basel 22 32
7. R.H. Nagaraj, I.N. Shipanova, and F.M. Faust J. Biol. Chem. 271 1996 19338 19345
8. M.U. Ahmed, S.R. Thorpe, and J.W. Baynes Biochem. J. 324 1997 565 570
9. V.M. Monnier Arch. Biochem. Biophys. 419 2003 1 15
10. M.U. Ahmed, S.R. Thorpe, and J.W. Baynes J. Biol. Chem. 261 1986 4889 4894
11. B.E. Brinkmann-Frye, T.P. Degenhardt, S.R. Thorpe, and J.W. Baynes J. Biol. Chem. 273 1998 18714 18719
12. K.J. Wells-Knecht, E. Brinkmann, and J.W. Baynes J. Org. Chem. 60 1995 6246 6247
13. D.R. Sell, and V.M. Monnier J. Biol. Chem. 264 1989 21597 21602
14. H. Odani, T. Shinzato, J. Usami, Y. Matsumoto, E. Brinkmann-Frye, J.W. Baynes, and K. Maeda FEBS Lett. 427 1998 381 385
15. M.O. Lederer, and H.P. Bühler Bioorg. Med. Chem. 7 1999 1081 1088
16. K. Iijima, M. Murata, H. Takahara, S. Irie, and D. Fujimoto Biochem. J. 347 2000 23 27
17. K.M. Biemel, D.A. Friedl, and M.O. Lederer J. Biol. Chem. 277 2002 24907 24915
18. K. Inoue, S. Sakakibara, and D.J. Prokop Biochem. Bophys. Acta 420 1976 133 141
19. + at m/z 3084
20. S. Uchiyama, T. Kai, K. Kajiyama, Y. Kobayashi, and T. Tomiyama Chem. Phys. Lett. 281 1997 92 96
21. 2-ribose and the incubation time of four weeks. Glycation with glyoxal was performed in 50 mM phosphate buffer (pH 8.5) with glyoxal (30 mM) at 40°C for 24 h. The glycated 3 in these three preparations was then passed through a PD-10 column to remove sugar or glyoxal
22. CML in 3 was detected in the hydrolysate (6 M HCl at 110°C for 24 h), which was subjected to amino acid analysis (L-8500, Hitachi). CML is known to be stable in these hydrolysis conditions and obtained as 20-30% of a lysine residue in the reaction with glyoxal
23. 21 and hydrolyzed with 6 M HCl at 110°C, 24 h. After phenylthio-carbamyl (PTC) derivatization with phenylisothiocyanate, CML and lysine were determined by HPLC on an ODS column eluting with 0.1% TFA-containing aqueous 15-35% MeCN with monitoring at 254 nm
24. 23 because of the presence of co-eluting multiple impurities
25. K.M. Reiser, M.A. Amigable, and J.A. Last J. Biol. Chem. 267 1992 24207 24216
26. P. Chellan, and R.H. Nagaraj Arch. Biochem. Biopys. 368 1999 98 104
27. Details will be published elsewhere